Literature DB >> 30898021

Controlled conductivity at low pH in Protein L chromatography enables separation of bispecific and other antibody formats by their binding valency.

Chen Chen1, Tetsuya Wakabayashi2, Masaru Muraoka1, Feng Shu1, Chia Wei Shan1, Chong Chor Kun1, Ching Tim Jang1, Ishin Soehano1, Yuichiro Shimizu1,2, Tomoyuki Igawa2,3, Jun-Ichi Nezu4.   

Abstract

The complex molecular formats of recent therapeutic antibodies, including bispecific antibodies, antibody fragments, and other fusion proteins, makes the task of purifying the desired molecules in a limited number of purification steps more and more challenging. Manufacturing these complicated biologics can be substantially improved in the affinity capture stage if the simple bind-and-elute mode is accompanied by targeted removal of the impurities, such as mis-paired antibodies and oligomers or aggregates. Here, we report a method, based on the binding valency to Protein L resin, of separating proteins during the elution step by simply controlling the conductivity at low pH. We show that the method efficiently separated targeted antibodies from mis-paired and aggregated species. Notably, the number of Protein L binding sites can be built into the molecule by design to facilitate the purification. This method may be useful for purifying various antibody formats at laboratory and manufacturing scales.

Keywords:  Immunoglobulin kappa light chain; Protein L; affinity purification; binding valency; conductivity

Mesh:

Substances:

Year:  2019        PMID: 30898021      PMCID: PMC6601544          DOI: 10.1080/19420862.2019.1583996

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  30 in total

1.  Optimizing expression and purification from cell culture medium of trispecific recombinant antibody derivatives.

Authors:  An Willems; Jannick Leoen; Steve Schoonooghe; Johan Grooten; Nico Mertens
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-03-25       Impact factor: 3.205

Review 2.  Recovery and purification process development for monoclonal antibody production.

Authors:  Hui F Liu; Junfen Ma; Charles Winter; Robert Bayer
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

3.  Selective high-performance liquid chromatographic purification of bispecific monoclonal antibodies.

Authors:  L Tarditi; M Camagna; A Parisi; C Vassarotto; L B DeMonte; M Letarte; F Malavasi; M Mariani
Journal:  J Chromatogr       Date:  1992-05-22

4.  Influence of the Hofmeister anions on protein stability as studied by thermal denaturation and chemical shift perturbation.

Authors:  Xavier Tadeo; Miquel Pons; Oscar Millet
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

Review 5.  Interactions between macromolecules and ions: The Hofmeister series.

Authors:  Yanjie Zhang; Paul S Cremer
Journal:  Curr Opin Chem Biol       Date:  2006-10-10       Impact factor: 8.822

6.  Protein stabilization and the Hofmeister effect: the role of hydrophobic solvation.

Authors:  Xavier Tadeo; Blanca López-Méndez; David Castaño; Tamara Trigueros; Oscar Millet
Journal:  Biophys J       Date:  2009-11-04       Impact factor: 4.033

Review 7.  Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies.

Authors:  Christian Klein; Claudio Sustmann; Markus Thomas; Kay Stubenrauch; Rebecca Croasdale; Jürgen Schanzer; Ulrich Brinkmann; Hubert Kettenberger; Jörg T Regula; Wolfgang Schaefer
Journal:  MAbs       Date:  2012-08-27       Impact factor: 5.857

8.  A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model.

Authors:  Takehisa Kitazawa; Tomoyuki Igawa; Zenjiro Sampei; Atsushi Muto; Tetsuo Kojima; Tetsuhiro Soeda; Kazutaka Yoshihashi; Yukiko Okuyama-Nishida; Hiroyuki Saito; Hiroyuki Tsunoda; Tsukasa Suzuki; Hideki Adachi; Taro Miyazaki; Shinya Ishii; Mika Kamata-Sakurai; Takeo Iida; Aya Harada; Keiko Esaki; Miho Funaki; Chifumi Moriyama; Eriko Tanaka; Yasufumi Kikuchi; Tetsuya Wakabayashi; Manabu Wada; Masaaki Goto; Takeshi Toyoda; Atsunori Ueyama; Sachiyo Suzuki; Kenta Haraya; Tatsuhiko Tachibana; Yoshiki Kawabe; Midori Shima; Akira Yoshioka; Kunihiro Hattori
Journal:  Nat Med       Date:  2012-09-30       Impact factor: 53.440

9.  Complex between Peptostreptococcus magnus protein L and a human antibody reveals structural convergence in the interaction modes of Fab binding proteins.

Authors:  M Graille; E A Stura; N G Housden; J A Beckingham; S P Bottomley; D Beale; M J Taussig; B J Sutton; M G Gore; J B Charbonnier
Journal:  Structure       Date:  2001-08       Impact factor: 5.006

10.  Identification and multidimensional optimization of an asymmetric bispecific IgG antibody mimicking the function of factor VIII cofactor activity.

Authors:  Zenjiro Sampei; Tomoyuki Igawa; Tetsuhiro Soeda; Yukiko Okuyama-Nishida; Chifumi Moriyama; Tetsuya Wakabayashi; Eriko Tanaka; Atsushi Muto; Tetsuo Kojima; Takehisa Kitazawa; Kazutaka Yoshihashi; Aya Harada; Miho Funaki; Kenta Haraya; Tatsuhiko Tachibana; Sachiyo Suzuki; Keiko Esaki; Yoshiaki Nabuchi; Kunihiro Hattori
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more
  3 in total

Review 1.  Current trends and challenges in the downstream purification of bispecific antibodies.

Authors:  Serene W Chen; Wei Zhang
Journal:  Antib Ther       Date:  2021-05-07

Review 2.  Modelling of pH-dependence to develop a strategy for stabilising mAbs at acidic steps in production.

Authors:  Max Hebditch; Ryan Kean; Jim Warwicker
Journal:  Comput Struct Biotechnol J       Date:  2020-03-10       Impact factor: 7.271

3.  Investigation of the effect of salt additives in Protein L affinity chromatography for the purification of tandem single-chain variable fragment bispecific antibodies.

Authors:  Serene W Chen; Darryl Tan; Yuan Sheng Yang; Wei Zhang
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.